Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TYPE-1 REPLICATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 138 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Duzgunes, N; Simoes, S; Slepushkin, V; Pretzer, E; Rossi, JJ; De Clercq, E; Antao, VP; Collins, ML; de Lima, MCP
      Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs deliveredin pH-sensitive liposomes

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    2. Paludan, SR; Malmgaard, L; Ellermann-Eriksen, S; Bosca, L; Mogensen, SC
      Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1

      EUROPEAN CYTOKINE NETWORK
    3. Kitaura, H; Ohara, N; Kobayashi, K; Yamada, T
      TNF-alpha-mediated multiplication of human immunodeficiency virus in chronically infected monocytoid cells by mycobacterial infection

      APMIS
    4. Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT
      Effect of coinfection with GB virus C on survival among patients with HIV infection.

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Hein, A; Martin, JP; Dorries, R
      In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats

      JOURNAL OF VIROLOGY
    6. Freitag, C; Chougnet, C; Schito, M; Near, KA; Shearer, GM; Li, C; Langhorne, J; Sher, A
      Malaria infection induces virus expression in human immunodeficiency virustransgenic mice by CD4 T cell-dependent immune activation

      JOURNAL OF INFECTIOUS DISEASES
    7. Schito, ML; Kennedy, PE; Kowal, RP; Berger, EA; Sher, A
      A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression

      JOURNAL OF INFECTIOUS DISEASES
    8. Kacani, L; Banki, Z; Zwirner, J; Schennach, H; Bajtay, Z; Erdei, A; Stoiber, H; Dierich, MP
      C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection

      JOURNAL OF IMMUNOLOGY
    9. Billaut-Mulot, O; Cocude, C; Kolesnitchenko, V; Truong, MJ; Chan, EKL; Hachula, E; de la Tribonniere, X; Capron, A; Bahr, GM
      SS-56, a novel cellular target of autoantibody responses in Sjogren syndrome and systemic lupus erythematosus

      JOURNAL OF CLINICAL INVESTIGATION
    10. Smith, SM; Khoroshev, M; Marx, PA; Orenstein, J; Jeang, KT
      Constitutively dead, conditionally live, HIV-1 genomes - Ex vivo implications for a live virus vaccine

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Boelaert, JR; Sperber, K; Piette, J
      The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea

      BIOCHEMICAL PHARMACOLOGY
    12. Lisziewicz, J; Zeng, G; Gratas, C; Weinstein, JN; Lori, F
      Combination gene therapy: Synergistic inhibition of human immunodeficiencyvirus Tat and Rev functions by a single RNA molecule

      HUMAN GENE THERAPY
    13. Marin, M; Pelegrin-Zurilla, M; Bachrach, E; Noel, D; Brockly, F; Piechaczyk, M
      Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein

      HUMAN GENE THERAPY
    14. Evans, JT; Garcia, JV
      Lentivirus vector mobilization and spread by human immunodeficiency virus

      HUMAN GENE THERAPY
    15. Kohn, DB
      Transduction of CD34+cells from the bone marrow of HIV-1-infected children: Comparative marking by an RRE decoy gene and a neutral gene

      HUMAN GENE THERAPY
    16. Li, Y; Starr, SE; Lisziewicz, J; Ho, WZ
      Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer

      GENE THERAPY
    17. Hogberg, M; Engelhardt, P; Vrang, L; Zhang, H
      Bioisosteric modification of PETT-HIV-1 RT-inhibitors: Synthesis and biological evaluation

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    18. Isaki, L; Kresina, TF
      Directions for biomedical research in alcohol and HIV: Where are we now and where can we go?

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    19. Kashiwase, H; Katsube, T; Iida, K; Komai, T; Nishigaki, T; Kimura, T; Yamashita, M
      Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity

      ARCHIVES OF VIROLOGY
    20. Angel, JB; Jacobson, MA; Skolnik, PR; Giordano, M; Shapiro, L; LeBeaut, A; Greaves, W; Fuchs, AC
      A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects

      AIDS
    21. Kedzierska, K; Maerz, A; Warby, T; Jaworowski, A; Chan, H; Mak, J; Sonza, S; Lopez, A; Crowe, S
      Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages

      AIDS
    22. Nath, A; Anderson, C; Jones, M; Maragos, W; Booze, R; Mactutus, C; Bell, J; Hauser, KF; Mattson, M
      Neurotoxicity and dysfunction of dopaminergic systems associated with AIDSdementia

      JOURNAL OF PSYCHOPHARMACOLOGY
    23. Todd, S; Anderson, CG; Jolly, DJ; Craik, CS
      HIV protease as a target for retrovirus vector-mediated gene therapy

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    24. Morse, GD; Reichman, RC; Fischl, MA; Para, M; Leedom, J; Powderly, W; Demeter, LM; Resnick, L; Bassiakos, Y; Timpone, J; Cox, S; Batts, D
      Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies

      ANTIVIRAL RESEARCH
    25. Balzarini, J
      Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors

      PHARMACOLOGY & THERAPEUTICS
    26. Szurek, PF; Brooks, BR
      Synthesis of virus-specific high-mobility DNA after temperature upshift ofSC-1 cells chronically infected with moloney murine leukemia virus mutant ts1

      JOURNAL OF VIROLOGY
    27. Dong, Q; Kelkar, S; Xiao, YH; Joshi-Barve, S; McClain, CJ; Barve, SS
      Ethanol enhances TNF-alpha-inducible NF kappa B activation and HIV-1-LTR transcription in CD4+jurkat T lymphocytes

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    28. Gopinath, R; Ostrowski, M; Justement, SJ; Fauci, AS; Nutman, TB
      Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro

      JOURNAL OF INFECTIOUS DISEASES
    29. Calzado, MA; Macho, A; Lucena, C; Munoz, E
      Hydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoter

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    30. Amirayan-Chevillard, N; Tissot-Dupont, H; Capo, C; Brunet, C; Dignat-George, F; Obadia, Y; Gallais, H; Mege, JL
      Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    31. Ongradi, J; Marodi, CL; Nagy, K; Csiszar, A; Banhegyi, D; Horvath, A
      Risk of HHV-6A primary and recurrent infections during the course of AIDS

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Margolis, D; Heredia, A; Gaywee, J; Oldach, D; Drusano, G; Redfield, R
      Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    33. Friedland, GH; Pollard, R; Griffith, B; Hughes, M; Morse, G; Bassett, R; Freimuth, W; Demeter, L; Connick, E; Nevin, T; Hirsch, M; Fischl, M
      Efficacy and safety of delavirdine mesylate with zidovudine and didanosinecompared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm(3) (ACTG 261)

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    34. Calistri, A; Parolin, C; Pizzato, M; Calvi, P; Giaretta, I; Palu, G
      Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    35. Bonura, F; Perna, AM; Vitale, F; Villafrate, MR; Viviano, E; Guttadauro, R; Mazzola, G; Romano, N
      Inhibition of human immunodeficiency virus 1 (HIV-1) by variant B of humanherpesvirus 6 (HHV-6)

      MICROBIOLOGICA
    36. Gelone, SP; Kostman, JR
      Hydroxyurea in the treatment of human immunodeficiency virus infection

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    37. Mayhew, CN; Phillips, JD; Greenberg, RN; Birch, NJ; Elford, HL; Gallicchio, VS
      In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity

      STEM CELLS
    38. Morel, F; Salimi, S; Markovits, J; Austin, TW; Plavec, I
      Hematologic recovery in mice transplanted with bone marrow stem cells expressing anti-human immunodeficiency virus genes

      HUMAN GENE THERAPY
    39. Daelemans, D; Vandamme, AM; De Clercq, E
      Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    40. Bertrand, E; Gwizdek, C; Fenard, D; Doglio, A
      RNAs as therapeutic molecules? Towards a rational development of antisenseRNA, ribozymes and aptamers

      M S-MEDECINE SCIENCES
    41. Hardy, MA; Nardacci, D
      Does valproate pose a threat to human immunodeficiency virus-infected patients?

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    42. Emery, VC; Atkins, MC; Bowen, EF; Clark, DA; Johnson, MA; Kidd, IM; McLaughlin, JE; Phillips, AN; Strappe, PM; Griffiths, PD
      Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: Evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6

      JOURNAL OF MEDICAL VIROLOGY
    43. Palmer, S; Shafer, RW; Merigan, TC
      Hydroxyurea enhances the activities of didanosine, 9-[2(phosphonylmethoxy)ethyl] adenine, and 9-[2(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    44. Pieroni, L; Bouille, P; Auclair, C; Guillosson, JJ; Nafziger, J
      Early steps of replication of moloney murine leukemia virus in resting lymphocytes

      VIROLOGY
    45. Hofmann, W; Schubert, D; LaBonte, J; Munson, L; Gibson, S; Scammell, J; Ferrigno, P; Sodroski, J
      Species-specific, postentry barriers to primate immunodeficiency virus infection

      JOURNAL OF VIROLOGY
    46. Lane, BR; Markovitz, DM; Woodford, NL; Rochford, R; Strieter, RM; Coffey, MJ
      TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression

      JOURNAL OF IMMUNOLOGY
    47. Wolday, D; Akuffo, H; Demissie, A; Britton, S
      Role of Leishmania donovani and its lipophosphoglycan in CD4(+) T-cell activation-induced human immunodeficiency virus replication

      INFECTION AND IMMUNITY
    48. Ravot, E; Lisziewicz, J; Lori, F
      New uses for old drugs in HIV infection - The role of hydroxyurea, cyclosporin and thalidomide

      DRUGS
    49. Hori, K; Burd, PR; Furuke, K; Kutza, J; Weih, KA; Clouse, KA
      Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: AstrocyticNO as a possible mediator of neural damage in acquired immunodeficiency syndrome

      BLOOD
    50. CASERTA MT; HALL CB
      A PRACTITIONERS GUIDE TO HUMAN HERPESVIRUS-6 (HHV-6) AND HUMAN HERPESVIRUS-7 (HHV-7)

      AIDS patient care and STDs
    51. HIRSCH MS
      REFLECTIONS ON THE ROAD TO EFFECTIVE HIV THERAPY

      Infectious diseases in clinical practice
    52. PELEGRIN M; MARIN M; NOEL D; PIECHACZYK M
      GENETICALLY-ENGINEERED ANTIBODIES IN GENE-TRANSFER AND GENE-THERAPY

      Human gene therapy
    53. PLAYER MR; MAITRA RK; SILVERMAN RH; TORRENCE PF
      TARGETING RNASE-L TO HUMAN-IMMUNODEFICIENCY-VIRUS RNA WITH 2-5A-ANTISENSE

      Antiviral chemistry & chemotherapy
    54. MEIER C; AUBERTIN AM; DEMONTE M; FARAJ A; SOMMADOSSI JP; PERIGAUD C; IMBACH JL; GOSSELIN G
      SYNTHESIS AND ANTIVIRAL EVALUATION OF SATE-FOSCARNET PRODRUGS AND NEWFOSCARNET-AZT CONJUGATES

      Antiviral chemistry & chemotherapy
    55. Marcello, A; Giaretta, I
      Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector

      RESEARCH IN VIROLOGY
    56. BUCUR SZ; LACKEY DA; ADAMS JW; LEE ME; VILLINGER F; MAYNE A; BRAY RA; WINTON EF; NOVEMBRE F; STROBERT EA; DEROSAYRO J; DAILEY PJ; ANSARI AA; HILLYER CD
      HEMATOLOGIC AND VIROLOGICAL EFFECTS OF LINEAGE-SPECIFIC AND NON-LINEAGE-SPECIFIC RECOMBINANT HUMAN AND RHESUS CYTOKINES IN A COHORT OF SIVMAC239-INFECTED MACAQUES

      AIDS research and human retroviruses
    57. Lund, OS; Hansen, JES
      Inhibition of HIV-1 replication by chimeric phosphorothioate oligodeoxynucleotides applied in free solution

      INTERVIROLOGY
    58. DEBOER RJ; BOUCHER CAB; PERELSON AS
      TARGET-CELL AVAILABILITY AND THE SUCCESSFUL SUPPRESSION OF HIV BY HYDROXYUREA AND DIDANOSINE

      AIDS
    59. LERZA R; CASTELLO G; BALLARINO P; MELA GS; TREDICI S; ARBOSCELLO E; MENCOBONI M; PANNACCIULLI I
      IN-VITRO TOXICITY OF A 3'-AZIDO-3'-DEOXYTHYMIDINE AND HYDROXYUREA COMBINATION ON NORMAL MYELOID PROGENITORS

      Anticancer research
    60. Cook, RT
      Alcohol abuse, alcoholism, and damage to the immune system - A review

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    61. CHANG M; SOOD VK; WILSON GJ; KLOOSTERMAN DA; SANDERS PE; SCHUETTE MR; JUDY RW; VOORMAN RL; MAIO SM; SLATTER JG
      ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF ATEVIRDINE IN THE RAT

      Drug metabolism and disposition
    62. MAITRA RK; SILVERMAN RH
      REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY 2',5'-OLIGOADENYLATE-DEPENDENT RNASE-L

      Journal of virology
    63. CHODOSH J; BOLDER VP; GAN YJ; BELGAUMI A; SAMPLE J; SIXBEY JW
      ERADICATION OF LATENT EPSTEIN-BARR-VIRUS BY HYDROXYUREA ALTERS THE GROWTH-TRANSFORMED CELL PHENOTYPE

      The Journal of infectious diseases
    64. SMITH TA; DAVIS E; CARPENTER S
      ENDOTOXIN TREATMENT OF EQUINE INFECTIOUS-ANEMIA VIRUS-INFECTED HORSE MACROPHAGE CULTURES DECREASES PRODUCTION OF INFECTIOUS VIRUS

      Journal of General Virology
    65. GRIFFITHS PD
      STUDIES OF VIRAL COFACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS IN-VITRO AND IN-VIVO

      Journal of General Virology
    66. DECLERCQ E
      NEW PERSPECTIVES FOR THE TREATMENT OF HIV-INFECTIONS

      Collection of Czechoslovak Chemical Communications
    67. JOHNS DG; GAO WY
      SELECTIVE DEPLETION OF DNA PRECURSORS - AN EVOLVING STRATEGY FOR POTENTIATION OF DIDEOXYNUCLEOSIDE ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS

      Biochemical pharmacology
    68. PERRAULT WR; SHEPHARD KP; LAPEAN LA; KROOK MA; DOBROWOLSKI PJ; LYSTER MA; MCMILLAN MW; KNOECHEL DJ; EVENSON GN; WATT W; PEARLMAN BA
      PRODUCTION SCALE SYNTHESIS OF THE NONNUCLEOSIDE REVERSE-TRANSCRIPTASEINHIBITOR ATEVIRDINE MESYLATE (U-87,201E)

      Organic process research & development
    69. PITHA PM
      REFLECTIONS ON THE YEARS IN INTERFERON RESEARCH

      Journal of interferon & cytokine research
    70. ZAPP ML; YOUNG DW; KUMAR A; SINGH R; BOYKIN DW; WILSON WD; GREEN MR
      MODULATION OF THE REV-RRE INTERACTION BY AROMATIC HETEROCYCLIC-COMPOUNDS

      Bioorganic & medicinal chemistry
    71. ROZENSKI J; MEIER C; AUBAGNAC JL; ASTIER R; HERDEWIJN P; IMBACH JL; GOSSELIN G
      FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRIC STUDY OF SATE FOSCARNET PRODRUGS AND OF A SERIES OF FOSCARNET-AZT CONJUGATES

      Rapid communications in mass spectrometry
    72. MAGNANI M; FRATERNALE A; CASABIANCA A; SCHIAVANO GF; CHIARANTINI L; PALAMARA AT; CIRIOLO MR; ROTILIO G; GARACI E
      ANTIRETROVIRAL EFFECT OF COMBINED ZIDOVUDINE AND REDUCED GLUTATHIONE THERAPY IN MURINE AIDS

      AIDS research and human retroviruses
    73. MILLER V; STASZEWSKI S; BOUCHER CAB; PHAIR JP
      CLINICAL-EXPERIENCE WITH NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS

      AIDS
    74. ZIDEK Z; HOLY A; FRANKOVA D
      IMMUNOMODULATORY PROPERTIES OF ANTIVIRAL ACYCLIC NUCLEOTIDE ANALOGS -CYTOKINE STIMULATORY AND NITRIC-OXIDE COSTIMULATORY EFFECTS

      International journal of immunopharmacology
    75. CARUSO M; BANK A
      EFFICIENT RETROVIRAL GENE-TRANSFER OF A TAT-REGULATED HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE FOR HIV GENE-THERAPY

      Virus research
    76. BORIN MT; CHAMBERS JH; CAREL BJ; FREIMUTH WW; AKSENTIJEVICH S; PIERGIES AA
      PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFABUTIN AND DELAVIRDINE MESYLATE IN HIV-1-INFECTED PATIENTS

      Antiviral research
    77. BABA M
      CELLULAR FACTORS AS ALTERNATIVE TARGETS FOR INHIBITION OF HIV-1

      Antiviral research
    78. TANG RY; SU Y
      CONSTRUCTION OF A CELL-BASED HIGH-FLUX ASSAY FOR THE REV PROTEIN OF HIV-1

      Journal of virological methods
    79. MAYHEW C; OAKLEY O; PIPER J; HUGHES NK; PHILLIPS J; BIRCH NJ; ELFORD HL; GALLICCHIO VS
      EFFECTIVE USE OF RIBONUCLEOTIDE REDUCTASE INHIBITORS (DIDOX AND TRIMIDOX) ALONE OR IN COMBINATION WITH DIDANOSINE (DDI) TO SUPPRESS DISEASEPROGRESSION AND INCREASE SURVIVAL IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS)

      Cellular and molecular biology
    80. LEVY JA
      3 NEW HUMAN HERPESVIRUSES (HHV6, HHV7, AND HHV8)

      Lancet
    81. BORIN MT; COX SR; HERMAN BD; CAREL BJ; ANDERSON RD; FREIMUTH WW
      EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS

      Antimicrobial agents and chemotherapy
    82. POPPE SM; SLADE DE; CHONG KT; HINSHAW RR; PAGANO PJ; MARKOWITZ M; HO DD; MO H; GORMAN RR; DUEWEKE TJ; THAISRIVONGS S; TARPLEY WG
      ANTIVIRAL ACTIVITY OF THE DIHYDROPYRONE PNU-140690, A NEW NONPEPTIDICHUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR

      Antimicrobial agents and chemotherapy
    83. PALMER S; COX S
      INCREASED ACTIVATION OF THE COMBINATION OF 3'-AZIDO-3'-DEOXYTHYMIDINEAND 2'-DEOXY-3'-THIACYTIDINE IN THE PRESENCE OF HYDROXYUREA

      Antimicrobial agents and chemotherapy
    84. MORSE GD; FISCHL MA; SHELTON MJ; COX SR; DRIVER M; DEREMER M; FREIMUTH WW
      SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Antimicrobial agents and chemotherapy
    85. BLOMER U; NALDINI L; KAFRI T; TRONO D; VERMA IM; GAGE FH
      HIGHLY EFFICIENT AND SUSTAINED GENE-TRANSFER IN ADULT NEURONS WITH A LENTIVIRUS VECTOR

      Journal of virology
    86. YAO XD; MATECIC M; ELIAS P
      DIRECT REPEATS OF THE HERPES-SIMPLEX VIRUS A SEQUENCE PROMOTE NONCONSERVATIVE HOMOLOGOUS RECOMBINATION THAT IS NOT DEPENDENT ON XPF ERCC4/

      Journal of virology
    87. BONYHADI ML; MOSS K; VOYTOVICH A; AUTEN J; KALFOGLOU C; PLAVEC I; FORESTELL S; SU LS; BOHNLEIN E; KANESHIMA H
      REVM10-EXPRESSING T-CELLS DERIVED IN-VIVO FROM TRANSDUCED HUMAN HEMATOPOIETIC STEM-PROGENITOR CELLS INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION

      Journal of virology
    88. ZHOU Y; CHANDRAN B; WOOD C
      TRANSCRIPTIONAL PATTERNS OF THE PCD41 (U27) LOCUS OF HUMAN HERPESVIRUS-6

      Journal of virology
    89. PONTZER CH; YAMAMOTO JK; BAZER FW; OTT TL; JOHNSON HM
      POTENT ANTI-FELINE IMMUNODEFICIENCY VIRUS AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS EFFECT OF IFN-TAU

      The Journal of immunology
    90. CHENG CL; SMITH DE; CARVER PL; COX SR; WATKINS PB; BLAKE DS; KAUFFMAN CA; MEYER KM; AMIDON GL; STETSON PL
      STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HIV-POSITIVE PATIENTS- EFFECT ON ERYTHROMYCIN BREATH TEST

      Clinical pharmacology and therapeutics
    91. BORIN MT; CHAMBERS JH; CAREL BJ; GAGNON S; FREIMUTH WW
      PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFAMPIN AND DELAVIRDINE MESYLATE

      Clinical pharmacology and therapeutics
    92. VILLAHERMOSA ML; MARTINEZIRUJO JJ; CABODEVILLA F; SANTIAGO E
      SYNERGISTIC INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY COMBINATIONSOF CHAIN-TERMINATING NUCLEOTIDES

      Biochemistry
    93. VANDERMEEREN M; JANSSENS S; BORGERS M; GEYSEN J
      DIMETHYLFUMARATE IS AN INHIBITOR OF CYTOKINE-INDUCED E-SELECTIN, VCAM-1, AND ICAM-1 EXPRESSION IN HUMAN ENDOTHELIAL-CELLS

      Biochemical and biophysical research communications
    94. YOKOCHI S; ISHIWATA Y; SAITO H; EBINUMA H; TSUCHIYA M; ISHII H
      STIMULATION OF ANTIVIRAL ACTIVITIES OF INTERFERON BY A LIVER EXTRACT PREPARATION

      Arzneimittel-Forschung
    95. BOIZIAU C; TARRAGOLITVAK L; SINHA ND; MOREAU S; LITVAK S; TOULME JJ
      ANTISENSE OLIGONUCLEOTIDES INHIBIT IN-VITRO CDNA SYNTHESIS BY HIV-1 REVERSE-TRANSCRIPTASE

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    96. SIMONELLI C; NASTI G; VACCHER E; TIRELLI U; ZANUSSI S; DEPAOLI P; COMAR M; GIACCA M
      HYDROXYUREA TREATMENT IN HIV-INFESTED PATIENTS

      Journal of acquired immune deficiency syndromes and human retrovirology
    97. KIM JH; MCLINDEN RJ; MOSCA JD; VAHEY MT; GREENE WC; REDFIELD RR
      INHIBITION OF HIV REPLICATION BY SENSE AND ANTISENSE REV RESPONSE ELEMENTS IN HIV-BASED RETROVIRAL VECTORS

      Journal of acquired immune deficiency syndromes and human retrovirology
    98. MUKHTAR M; DUAN L; BAGASRA O; POMERANTZ RJ
      EVALUATION OF RELATIVE PROMOTER STRENGTHS OF THE HIV-1-LTR AND A CHIMERIC RSV-LTR IN T-LYMPHOCYTIC CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PROMOTERS FOR ANTI-HIV-1 GENE THERAPIES

      Gene therapy
    99. CAPUTO A; GROSSI MP; BOZZINI R; ROSSI C; BETTI M; MARCONI PC; BARBANTIBRODANO G; BALBONI PG
      INHIBITION OF HIV-1 REPLICATION AND REACTIVATION FROM LATENCY BY TAT TRANSDOMINANT NEGATIVE MUTANTS IN THE CYSTEINE-RICH REGION

      Gene therapy
    100. ZHANG H; VRANG L; RYDERGARD C; AHGREN C; OBERG B
      SYNERGISTIC INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE AND HIV-1 REPLICATION BY COMBINING TROVIRDINE WITH AZT, DDL AND DDC IN-VITRO

      Antiviral chemistry & chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 08:25:15